Results 181 to 190 of about 918,150 (305)
Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis. [PDF]
McNair E +10 more
europepmc +1 more source
Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy
IL‐12 levels are tightly regulated to balance effective protective immunity against infections and cancer with the risk of excessive inflammation and autoimmune disease. Both insufficient and excessive IL‐12 activity can therefore be detrimental, highlighting the importance of precisely controlling its production and signaling. ABSTRACT Interleukin‐12 (
Anthi Psoma, Geert van den Bogaart
wiley +1 more source
Novel RT‒qPCR-based blood signatures for the diagnosis of pulmonary tuberculosis. [PDF]
Horta T +10 more
europepmc +1 more source
Anthracofibrosis: an under‐recognised mimic of malignancy and tuberculosis in a migrant population
Abstract Anthracosis, usually regarded as a benign and uncommon bronchoscopic finding, was identified in 108 (9.9%) of 1154 bronchoscopy procedures at two Australian hospitals, with almost a third showing bronchial narrowing consistent with anthracofibrosis.
Wai Yiu +2 more
wiley +1 more source
Primary pulmonary leiomyosarcoma in a patient with disseminated pulmonary tuberculosis and constrictive pericarditis. [PDF]
Van Der Westhuizen S +5 more
europepmc +1 more source
Improving timeliness of lung cancer care through a rapid assessment clinic
Abstract Background Early diagnosis and treatment of lung cancer improve survival. Guidelines from Australia and worldwide stipulate timeframes of care from referral. The Rapid Lung Assessment Clinic (RLAC) was established to fast‐track the diagnostic and treatment pathway, with a subsequent quality improvement initiative based on the initial analysis ...
Shakti V. Dabholkar +6 more
wiley +1 more source
An ensemble model approach for identifying pulmonary tuberculosis on chest X-ray. [PDF]
Qin W, Hu Q, Jing J.
europepmc +1 more source
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley +15 more
wiley +1 more source
Pulmonary Tuberculosis and Pregnancy [PDF]
openaire +2 more sources

